PeopleBio, Inc. (KOSDAQ:304840)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,490.00
+29.00 (1.98%)
At close: Apr 24, 2026
Market Cap30.93B -44.0%
Revenue (ttm)2.85B +12.6%
Net Income-15.71B
EPS-722.00
Shares Out21.17M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume344,100
Average Volume1,647,322
Open1,460.00
Previous Close1,461.00
Day's Range1,423.00 - 1,515.00
52-Week Range600.00 - 3,195.00
Beta0.00
RSI68.11
Earnings DateApr 3, 2026

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam-si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2002
Employees 46
Stock Exchange KOSDAQ
Ticker Symbol 304840
Full Company Profile

Financial Performance

In 2025, PeopleBio's revenue was 2.85 billion, an increase of 12.64% compared to the previous year's 2.53 billion. Losses were -15.71 billion, 44.0% more than in 2024.

Financial Statements